These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1113 related items for PubMed ID: 19623018

  • 1. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure.
    Cai J, Terasaki PI, Anderson N, Lachmann N, Schönemann C.
    Transplantation; 2009 Jul 27; 88(2):226-30. PubMed ID: 19623018
    [Abstract] [Full Text] [Related]

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Jul 27; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May 27; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

  • 9. Antibodies against MICA antigens and kidney-transplant rejection.
    Zou Y, Stastny P, Süsal C, Döhler B, Opelz G.
    N Engl J Med; 2007 Sep 27; 357(13):1293-300. PubMed ID: 17898098
    [Abstract] [Full Text] [Related]

  • 10. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads.
    Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S.
    Transplantation; 2009 Jun 15; 87(11):1681-8. PubMed ID: 19502960
    [Abstract] [Full Text] [Related]

  • 11. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G, Furst D, Mytilineos J, Pourmand G, Amirzargar AA.
    Transpl Immunol; 2012 Mar 15; 26(2-3):81-7. PubMed ID: 22182633
    [Abstract] [Full Text] [Related]

  • 12. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A, Siddiqui JA, Rai A, Margoob A, Khaira A, Bhowmik D, Tiwari SC, Guleria S, Mehra NK.
    Clin Transpl; 2007 Mar 15; ():211-7. PubMed ID: 18637472
    [Abstract] [Full Text] [Related]

  • 13. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 14. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE, Martin S, Al-Husseini DM, Dyer PA, Johnson RW.
    Transplantation; 2003 Apr 15; 75(7):1034-40. PubMed ID: 12698094
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies.
    Amico P, Hönger G, Bielmann D, Lutz D, Garzoni D, Steiger J, Mihatsch MJ, Dragun D, Schaub S.
    Transplantation; 2008 Jun 15; 85(11):1557-63. PubMed ID: 18551059
    [Abstract] [Full Text] [Related]

  • 17. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L, Conca R, Magistroni P, Leonardi G, Oda A, Rosati F, Leone E, Tacconella M, Roggero S, Segoloni GP, Amoroso A.
    Transpl Immunol; 2008 Jul 15; 19(3-4):238-43. PubMed ID: 18675725
    [Abstract] [Full Text] [Related]

  • 18. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S, Hourmant M, Valentin N, Paitier C, Giral-Classe M, Curry S, Follea G, Soulillou JP, Bignon JD.
    Transplantation; 2003 Feb 27; 75(4):477-82. PubMed ID: 12605113
    [Abstract] [Full Text] [Related]

  • 19. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V, Venetz JP, Pantaleo G, Pascual M.
    Hum Immunol; 2009 Aug 27; 70(8):580-3. PubMed ID: 19375474
    [Abstract] [Full Text] [Related]

  • 20. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S.
    J Heart Valve Dis; 2003 May 27; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 56.